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Abstract: Protein tyrosine phosphatase 1B (PTP1B) is an intracellular enzyme responsible for
deactivation of the insulin receptor, and consequently acts as a negative regulator of insulin signal
transduction. In recent years, PTP1B has become an important target for controlling insulin resistance
and type 2 diabetes. In the present study, the ethyl acetate extract of leaves of Miconia albicans
(IC50 = 4.92 µg/mL) was assessed by high-resolution PTP1B inhibition profiling combined with
HPLC-HRMS-SPE-NMR for identification of antidiabetic compounds. This disclosed eleven PTP1B
inhibitors, including five polyphenolics: 1-O-(E)-caffeoyl-4,6-di-O-galloyl-β-D-glucopyranose (2),
myricetin 3-O-α-L-rhamnopyranoside (3), quercetin 3-O-(2”-galloyl)-α-L-rhamnopyranoside (5),
mearnsetin 3-O-α-L-rhamnopyranoside (6), and kaempferol 3-O-α-L-arabinopyranoside (8) as
well as eight triterpenoids: maslinic acid (13), 3-epi-sumaresinolic acid (14), sumaresinolic
acid (15), 3-O-cis-p-coumaroyl maslinic acid (16), 3-O-trans-p-coumaroyl maslinic acid (17),
3-O-trans-p-coumaroyl 2α-hydroxydulcioic acid (18), oleanolic acid (19), and ursolic acid (20).
These results support the use of M. albicans as a traditional medicine with antidiabetic properties and
its potential as a source of PTP1B inhibitors.
Keywords: Miconia albicans; type 2 diabetes; PTP1B; HPLC-HRMS-SPE-NMR
1. Introduction
Type 2 diabetes is a metabolic syndrome caused by an unbalanced production and/or action
of the hormone insulin. Pancreatic β-cells produce insulin as a response to increased blood glucose
after digestion of carbohydrates. When insulin binds to the insulin receptor, several downstream
signaling pathways become activated, leading to an uptake of glucose from the bloodstream into
the cells [1–3]. For type 2 diabetics, cells from liver and muscles display a decreased response
to the insulin stimuli, i.e., they are insulin-resistant, and the resulting decreased glucose uptake
leads to hyperglycemia. Insulin resistance is caused by malfunctions in signal transduction such as
impaired activation of the insulin receptor tyrosine kinase or down-regulation of the insulin-stimulated
phosphatidylinositol-3-OH kinase (PI3K) [4–6]. Therefore, enzymes involved in this signaling pathway
constitute promising targets for managing insulin resistance and for treatment of T2D patients.
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Protein tyrosine kinase 1B (PTP1B) is an intracellular enzyme involved in the negative regulation
of insulin signaling by dephosphorylating the activated insulin receptor, and consequently PTP1B
inhibitors promote a prolonged effect of insulin [6]. However, at present, there are no PTP1B inhibitors
in clinical use, and PTP1B is therefore an intriguing target in the search for new therapeutic alternatives
to the drugs currently available for managing T2D.
Miconia is a genus comprising approximately 1000 species of flowering plants belonging to the
family Melastomataceae, and it is native to neo-tropical forests and widely spread in warm areas of the
American continent [7]. Miconia albicans is a shrub commonly found on the Brazilian savannah and in
the Brazilian rain forests. Extracts obtained from various Miconia species have been reported to exhibit
antifungal, analgesic, and antiprotozoal activity as well as α-amylase and α-glucosidase inhibitory
activity. Although M. albicans is used as a traditional anti-inflammatory medicine in Brazil and for
treatment of diabetes in Mexico, the pharmacological properties of this plant species have not yet
been investigated in detail. Few studies have reported its antifungal and antibacterial activity as well
as its protective effects towards doxorubicin-induced DNA damage, but the individual constituents
responsible for these effects have not been identified. The only studies of the phytochemistry of
M. albicans led to isolation of the triterpenes α-amyrin and β-amyrin, and the steroids β-sitosterol and
stigmasterol [8–11].
Bioassay-guided fractionation is a widely used method for identification of bioactive
constituents in crude plant extracts, but it is usually both laborious and time-consuming. Thus,
the combined use of high-resolution inhibition profiling (HR-inhibition profiling) that pinpoints
individual bioactive constituents and high-performance liquid chromatography—high-resolution
mass spectrometry—solid-phase extraction—and nuclear magnetic resonance spectroscopy
(HPLC-HRMS-SPE-NMR) that allows structural identification from analytical-scale HPLC analysis,
can accelerate the search for bioactive constituents in complex plant extracts. HR-inhibition
profiling/HPLC-HRMS-SPE-NMR have already been used for accelerated identification of
α-glucosidase inhibitors [12,13], α-amylase inhibitors [14], PTP1B inhibitors [15], monoamine oxidase
inhibitors [16], and antioxidants [17,18] directly from crude extracts of foods and herbal medicine.
In this study, we report the PTP1B inhibitory activity of crude defatted ethyl acetate extract of
M. albicans as well as the identification of several active polyphenolics and triterpenoids by the
use of high-resolution PTP1B inhibition profiling combined with HPLC-HRMS-SPE-NMR.
2. Results
The crude defatted extract of M. albicans was found to possess high PTP1B inhibitory activity
with an IC50 value of 4.92 ± 0.31 µg/mL (as determined from the dose-response curve shown in
Supplementary Material Figure S1), and it was therefore decided to identify some of the bioactive
constituents responsible for this inhibitory activity.
2.1. High-Resolution PTP1B Inhibition Profiling and Identification of Active Compounds from Crude Extract of
M. albicans
The crude extract was subjected to high-resolution PTP1B inhibition profiling, and the
biochromatogram (Figure 1) displayed 12 distinct peaks corresponding to moderate to strong activity
eluting between 32 and 62 min. In addition, two large humps with around 100% inhibition were
observed in the retention ranges 64–75 min and 75–90 min. Initially, HPLC-HRMS-SPE-NMR analysis
of crude extract was performed to identify the material eluted with HPLC peaks 1–12, which are
correlated with PTP1B inhibitory activity. HRMS and NMR data are reported in Supplementary
Material Table S1.
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quercetin 3-O-(2′′-galloyl)-α-L-rhamnopyranoside [21]. 
Figure 1. High-resolution PTP1B inhibition profiling of the crude ethyl acetate extract of M. albicans.
Black trace: UV absorption at 254 nm; Green trace: PTP1B inhibition profiling.
The material eluting with peak 1 showed a molecular ion with m/z 615.0997 [M−H]− suggesting
the presence of a compound with molecular formula C28H24O16 (∆M = −0.8 ppm), but the amount
and purity of the material did not allow for further structural information based on NMR.
The compound eluting with peak 2 showed a molecular ion with m/z 647.1214 [M + H]+
suggesting a molecular formula of C29H26O17 (∆M = 4.4 ppm). The 1H NMR spectrum showed
characteristic signals for a caffeoyl group (δ 7.58, 1H, d, 16.0 Hz, -2′; δ 7.77, 1H, d, 2.1. Hz, H-4′;
δ 7.55, 1H, dd, 8.3, 2.1 Hz, -8′; δ 7.06, 1 , d, 8.3 z, H-7′; δ 6.28, 1H, d, 16.0 Hz, H-1′), two galloyl
groups (δ 6.97 and 6.90, s, 2H each, H-3”/H-7” and -3”’/H-7”’), and a 1,4,6-triacylated glucose
moiety (δ 5.10, 1H, d, 8.0 Hz, H-1; δ 4.56, 1H, m, H-4; δ 4.46, 1H, dd, 11.3, 7.6 Hz, H-6B; δ 4.33, 1H,
dd, 11.3, 7.0 Hz, H-6A). Comparis n with 1H NMR data from literature led to identification of 2 as
1-O-(E)-caffeoyl-4,6-di-O-galloyl-β-D-glucopyranose [19] (Figure 2).
The material eluting with peaks 3 and 4 showed molecular ions with m/z 463.0880 [M − H]− and
m/z 599.1047 [M − H]−, sugg sting molecular formulas of C21H20O12 (∆M = 0.4 ppm) and C28H24O15
(∆M = −0.8 ppm), respectively. The 1H NMR spectrum of 3 showed signals ch racte istic for myricetin
(δ 6.95, 2H, s, H-2′/H-6′; δ 6.37, 1H, d, 2.2 Hz, H-8; δ 6.20, 1H, d, 2.2 z, H-6), and a rhamnose unit (δ
5.32, 1H, d, 1.5 Hz, H-1”; δ 4.22, 1H, dd, 3.4, 1.7 Hz, H-2”; δ 0.94, H, d, 6.8 Hz, H-6”). C mparison with
literature data allowed identification of 3 as myricetin 3-O-α-L-rhamn pyranosid [20]. The olecular
formula of 4 might indicate this compound to be a galloylat d quercetin rhamnosid . However,
the amount and purity of the material eluted with peak 4 did not allow further structural information
based on NMR spectroscopy.
The compound el ting as peak 5 showed a molecular ion of m/z 599.1041 [M−H]− suggesting the
molecular formula C28H24O15 (∆M = 0.2 ppm). The 1H NMR spectrum displayed signals characteristic
for quercetin (δ 7.34, 1 , d, 2.1 Hz, H-2′; δ 7.30, 1H, dd, 8.5, 2.1 Hz, H-6′; δ 2.92, 1H, d, 8.5 Hz, H-5′;
δ 6.38, 1H, d, 2.1 Hz, H-8; δ 6.21, 1H, d, 2.1 Hz, H-6), a galloyl unit (δ 6.89, 2H, s), and a rhamnose
unit (δ 5.34, 1H, d, 1.8 Hz, H-1”; δ 4.78, 1H, dd, 3.4, 1.7 Hz, H-2”; δ 3.75, 1H, dd, 9.5, 3.4 Hz, H-3”;
δ 3.34, m, H-4”; δ 3.42, 1H, dd, 9.3, 6.2 Hz, H-5”; δ 0.94, 3H, d, 6.8 Hz, H-6”). This indicated 5 to be a
galloylated quercetin rhamnoside, and the downfield shift of H-2” (δ 4.78) inferred the galloyl unit
to be attached in position 2”. Comparison with data from literature allowed identification of 5 as
quercetin 3-O-(2”-galloyl)-α-L-rhamnopyranoside [21].
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Figure 2. PTP1B inhibitory polyphenolics from extract of M. albicans.
The compound eluting with peak 6 exhibited a molecular ion with m/z 477.1041 [M − H]−
suggesting the molecular formula C20H22O12 (∆M = −0.5 ppm). The 1H NMR spectrum showed
a singlet at δ 6.88 (2H, H-2”/H-6”) together with two doublets at δ 6.38 and 6.22, each integrating
to 1H (JH-6,H-8 = 2.0 Hz) corresponding to H-6 and H-8 being meta-positioned. An additional 3H
singlet at δ 3.88 indicated the presence of a methoxy group, and HMBC correlations showed it to
be attached to C-4′. A doublet at δ 5.31 ppm (1H, JH-1”,H-2” = 1.8 Hz) together with a doublet at δ
0.94 (3H, J H-6”,H-5” = 6.8 Hz, H-6”) and signals in the region δ 3.33–4.25 suggested the presence of a
rhamnose moiety. Comparison of these data with literature allowed identification of 6 as mearnsetin
3-O-α-L-rhamnopyranoside [22].
The material eluting with peak 8 showed a molecular ion with m/z 417.0825 [M−H]− suggesting
the molecular formula C20H18O10 (∆M = 0.5 ppm). The 1H NMR spectrum contained signals
corresponding to kaempferol (δ 8.06 and 6.89, 2H each, AA’ and XX’ systems; δ 6.41, 1H, d, 2.1 Hz,
H-8; δ 6.21, 1H, d, 2.1 Hz, H-6) and an arabinose unit (δ 5.14, 1H, d, 6.4 Hz, H-1” and signals from δ
3.15–3.80, 5H). Comparison with 1H NMR data from literature allowed identification of 8 as kaempferol
3-O-α-L-arabinopyranoside [23] (Figure 2).
The HRMS data and the inferred molecular formula of the compounds eluting with peaks 7 and
9–12 are given in Table S1 in Supplementary Data, but the amount and purity of these compounds did
not allow further structural identification.
Dereplication of the hump from 64 to 75 min correlated with PTP1B inhibitory activity, and based
on LC-ESI-HRMS/MS data it showed losses of [M − H − 44]− and [M − H − 62]−, corresponding to
a loss of CO2 and CO2 + H2O, which is common for lipids (fatty acids). This suggested that this area
contained large amounts of structurally related lipids. Two previous studies have shown that some
classes of lipids possess PTP1B inhibitory activity [24,25], which could support the activity observed in
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the biochromatogram, but the amount and purity of material obtained from this region did not allow
structural identification of individual metabolites.
HRMS-based dereplication of peaks eluting from 75 to 90 min suggested the presence of several
structurally related pentacyclic triterpenes and saponins. There is a growing interest in naturally
occurring triterpenoids because they exhibit a wide spectrum of biological activities including
antibacterial, fungicidal, antiviral, cytotoxic, anticancer, and cardiovascular activity. In addition to this,
some triterpenoids inhibit PTP1B, a key regulatory enzyme for regulation of blood glucose [26–30].
The fraction eluting from 75 to 90 min was therefore isolated by preparative-scale HPLC (hereafter
called fraction F1) to allow further analysis using high-resolution PTP1B inhibition profiling combined
with HPLC-HRMS-SPE-NMR.
2.2. High-Resolution PTP1B Inhibition Profiling and Identification of Active Compounds from F1
High-resolution PTP1B inhibition profiling of the triterpenoid-containing fraction F1 obtained by
preparative-scale HPLC provided the biochromatogram shown in Figure 3. This displayed several
HPLC peaks correlated with moderate to strong PTP1B-inhibitory activity—varying from 33% to
95% inhibition. Initial dereplication of the chromatographic peaks eluted from fraction F1 indicated,
based on HRMS and UV data, the presence of several structural isomers of triterpenoids. This fraction
was therefore further analyzed by HPLC-HRMS-SPE-NMR to enable identification of PTP1B-inhibitory
triterpenoids. Thus, peaks 13–20 were cumulatively trapped (from 10 consecutive separations) on
Hysphere GP-resin cartridges based on threshold levels from the UV chromatogram (254 or 280 nm),
total ion chromatogram or base peak chromatogram. After drying with nitrogen gas, the trapped
metabolites were eluted into 1.7-mm NMR tubes, and 600 MHz spectra were acquired.
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Figure 3. High-resolution PTP1B inhibition profiling of fraction F1. Black trace: UV absorption at
200 nm; Green trace: PTP1B inhibition profiling.
The compound obtained by repeated trapping of peak 13 showed a molecular ion with m/z
473.3620 [M + H]+ suggesting the molecular formula C30H48O4 (∆M = 0.5 ppm). The 1H NMR
spectrum revealed the presence of signals characteristic of an olean-12-en-oic acid: a single olefinic
proton (δ 5.27, t, 3.6 Hz, H-12), seven methyl groups: δ 1.00 (CH3-23), δ 0.81 (CH3-24), δ 1.01 (CH3-25),
δ 0.82 (CH3-26), δ 1.16 (CH3-27), δ 0.91 (CH3-29), and δ 0.94 (CH3-30), a triplet of doublets at δ 3.62 (1H,
9.5 and 4.1 Hz, H-2) and a doublet at δ 2.91 (9.5 Hz, H-3) indicating two trans-diaxial protons both
connected to oxygenated carbons. Comparison with 1H NMR data from literature confirmed 13 to be
maslinic acid [31] (Figure 4).
The compound obtained by repeated trapping of peak 14 showed a molecular ion with m/z
473.3625 [M + H]+ suggesting the molecular formula C30H48O4 (∆M = 1.7 ppm). The 1H NMR
spectrum displayed signals similar to those for compound 13, indicating that 14 was an olean-12-en-oic
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acid as well. The presence of signals at δ 1.48 (1H, dq, JH2eq,H2ax = 14.4 and JH2eq,H1eq = JH2eq,H1ax =
JH2eq,H3eq = 3.2 Hz, H-2α), δ 2.03 (1H, dddd, JH2ax,H2eq = 14.4, JH2ax,H1ax = 9.5, JH2ax,H1eq = 3.3, JH2ax,H3eq
= 2.8 Hz, H-2β), and a triplet at δ 3.28 (1H, JH3eq,H2ax = JH3eq,H2eq = 2.8 Hz, H-3) show that C-3 has
a β-positioned equatorial hydrogen and an α-positioned axial hydroxy group. The signal for H-6
at δ 4.37 is a broad singlet, with only equatorial-equatorial and equatorial-axial couplings, showing
a β-positioned axial hydroxy group. Analysis of COSY, NOESY, HSQC and HMBC spectra as well
as comparison with 1H and 13C NMR data from literature of the related methyl ester [32] allowed
identification of 14 as 3-epi-sumaresinolic acid (Figure 4).
The compound obtained by repeated trapping of peak 15 showed also a molecular ion with m/z
473.3618 [M + H]+ suggesting the same molecular formula C30H48O4 (∆M = 1.5 ppm). The 1H NMR
spectrum displayed signals similar to those for compound 14, but with H-3 appearing at δ 3.06 as a
doublet of doublet with JH3ax,H2ax = 12 Hz and JH3ax,H2eq = 4.1 Hz. Analysis of COSY, NOESY, HSQC
and HMBC spectra as well as comparison with 1H and 13C NMR data from literature of the related
methyl ester [32] allowed identification of 15 as sumaresinolic acid (Figure 4).
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The compounds obtained by repeated trapping of peaks 16 and 17 showed molecular ions with
m/z 619.3979 [M + H]+ and m/z 619.3989 [M + H]+, suggesting molecular formulas of C39H54O6
for both 16 and 17 (∆M = 2.7 and 0.7 ppm, respectively). The 1H NMR spectra resembled that of 13
but revealed additional signals for an AA’XX’ aromatic system as well as two cis-positioned olefinic
protons (δ 6.88 and δ 5.85, 1H each, 12.8 Hz) for 16 and two trans-positioned olefinic protons (δ 7.64
and δ 6.81, 1H each, 15.9 Hz) for 17. This indicated 16 and 17 to be cis- and trans-coumaroyl esters
of 13. A clear downfield shift of H-3 from δ 2.91 in 13 to δ 4.63 in 16 and δ 4.64 in 17, shows the
coumaroyl unit to be attached at C-3 in both compounds. By comparison of these 1H NMR data
with literature data the structure of 16 and 17 were assigned as 3-O-cis-p-coumaroyl-maslinic acid
and 3-O-trans-p-coumaroyl-maslinic acid, respectively [33]. The compound obtained by repeated
trapping of peak 18 showed also a molecular ion of m/z 619.3974 [M + H]+ suggesting the same
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molecular formula C39H54O6 (∆M = 3.1 ppm) as that of 16 and 17. The 1H NMR spectrum showed
signals characteristic of an aromatic AA’XX’ system and two trans-coupled olefinic protons (δ
7.63 and 6.38, 1H each, 15.8 Hz) inferring the presence of a trans-coumaroyl unit. Contrary to
the seven methyl singlets observed for 13–17, the 1H NMR spectrum of 18 showed six methyl
singlets and a methyl doublet attributed to a methyl group at C-19 (δ 0.95, 3H, d, 6.1 Hz, CH3-29).
Further analysis based on 1D and 2D NMR and comparison with literature data established that 18
was 3-O-trans-p-coumaroyl-2α-hydroxydulcioic acid [34] (Figure 4).
The compound obtained by repeated trapping of peak 19 showed a molecular ion with m/z
457.3668 [M + H]+ suggesting the molecular formula C30H48O3 (∆M = 1.8 ppm). Similar to the
spectra of 13–15, the 1H NMR spectrum of 19 displayed signals characteristic of an olean-12-oic acid,
and comparison with NMR data from literature allowed identification of 19 as oleanolic acid [35]
(Figure 4). The compounds obtained by repeated trapping of peak 20 showed a molecular ion with
m/z 457.3672 [M + H]+ suggesting the molecular formula C30H48O3 (∆M = 0.9 ppm). The 1HNMR
spectrum of 20, showed signals characteristic of an ursan-12-oic acid, and comparison with NMR
data from literature allowed identification of 20 as ursolic acid [36]. NMR data of 13–20 are given in
Supplementary Material (Table S1).
Dose-response curves of 13–20 are shown in Supplementary Material (Figure S2), and the derived
IC50 values are presented in Table 1. Maslinic acid has previously been reported as a bioactive
pentacyclic triterpene acid, with anti-tumor, antioxidant, anti-HIV, and antimicrobial activity. In this
study 13 was identified as a PTP1B inhibitor with an IC50-value of 3.21± 0.8 µM, which is in agreement
with the previously reported IC50-value of 5.93 µM [29]. Moreover, studies suggest that PTP1B
inhibition of this type of pentacyclic triterpenes is affected by the configuration and substituents at C-2
and C-3 [30]. Although the biochromatogram does not give quantitative pharmacological responses,
Figure 3 shows that compounds 16 (IC50: 0.46 ± 0.07 µM), 17 (IC50: 1.08 ± 0.32 µM), and 18 (IC50:
1.6 ± 0.50 µM) with a coumaroyl unit at C-3 are correlated with higher PTP1B inhibitory activity as
compared to that of 13. According to Qiu and colleagues [30], this structural feature may not only
increase the potency but also improve the selectivity of these compounds for PTP1B. PTP1B belongs to
the protein tyrosine kinases (PTPs), a family comprising approximately 100 enzymes that are involved
in vital processes in the human body, and it has therefore been a challenge to identify selective PT1B
inhibitors that might be developed into new medicines [6,30,37]. The present work demonstrates that
M. albicans constitute a rich source of new potent 3-coumaroyl analogues of maslinic acid, and presents
the PTP1B inhibitory activity of 14–18 for the first time. However, further studies are needed to
investigate their potential as selective PTP1B inhibitors.
Table 1. IC50 values of compounds 13–20 isolated from leaves of Miconia albicans.
Compound Name IC50 (µM) a
13 Maslinic acid 3.21 ± 0.8
14 3-epi-sumaresinolic acid 2.87 ± 0.4
15 Sumaresinolic acid 1.84 ± 0.3
16 3-O-cis-p-coumaroyl-maslinic acid 0.46 ± 0.07
17 3-O-trans-p-coumaroyl-maslinic acid 1.08 ± 0.3
18 3-O-trans-p-coumaroyl-2α-hydroxydulcioic acid 1.6 ± 0.5
19 Oleanolic acid 2.88 ± 0.6
20 Ursolic acid 2.18 ± 0.8
a n = 3.
3. Materials and Methods
3.1. Chemicals and Reagents
p-Nitrophenyl phosphate (pNPP), dimethyl sulfoxide (DMSO), sodium phosphate monobasic
dihydrate, sodium phosphate dibasic, sodium hydroxide, sodium azide, tris-(hydroxymethyl)-
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aminomethane (Tris), bis-(2-hydroxyethyl)-imino-tris-(hydroxymethylmethane) (Bis-Tris), N,N,N′,N′-
ethylenediaminetetraacetate (EDTA), dithiothreitol (DTT), methanol-d4, and HPLC grade acetonitrile
were purchased from Sigma-Aldrich (St. Louis, MO, USA), recombinant human PTP1B
(BML-SE332-0050, EC 3.1.3.48) was purchased from Enzo Life Sciences Inc. (Farmingdale, NY, USA),
and formic acid was purchased from Merck (Darmstadt, Germany). Water was purified by deionization
and filtration through a 0.22 µm membrane (Millipore, Billerica, MA, USA).
3.2. Preparation of Crude Ethyl Acetate Extracts of Leaves of M. albicans
Leaves of Miconia albicans were collected in the National Park of Chapada dos Veadeiros (Alto
Paraíso de Goiás, GO, Brazil) in February 2016, identified by botanist Dr. Marcos José da Silva
(Universidade Federal de Goiás), and a voucher specimen was deposited at the herbarium of
Universidade Federal de Goiás with accession number UFG 7163. The leaves were dried and powdered,
and a batch (139.2 g) of this plant material was extracted twice with ethyl acetate (1.0 L) for 2 h under
sonication. The extract was filtered and concentrated under reduced pressure to afford a crude extract
(9.0 g). Fatty acids and chlorophylls were removed by liquid-liquid partitioning between 90% (v/v)
methanol (0.1 L) and petroleum ether (0.9 L), yielding a crude defatted extract (4.0 g) after evaporation
of the methanol fraction under reduced pressure.
3.3. Microplate-Based PTP1B Inhibition Assay
PTP1B inhibition assaying of the defatted extract, fraction F1 (from preparative HPLC: see
Section 3.5) and microfractions (obtained as described below in Section 3.4) were performed according
to the microplate-based method previously described [38]. In brief, all solutions were prepared in a
buffer of 50 mM Tris and 50 mM Bis-Tris containing 100 mM NaCL and adjusted to pH 7. To each
well containing microfractions or dilution series of pure compounds were added 18 µL of DMSO
and 52 µL of 3.4 mM EDTA in Bis-Tris buffer (to give final well concentrations of 10% DMSO and
1 mM EDTA) as well as 60 µL of a Bis-Tris buffer solution containing 1.5 mM pNPP and 6 mM DTT in
phosphate buffer (to give final well concentrations of 0.5 mM pNPP and 2 mM DTT). The microplate
was incubated for 10 min at 25 ◦C, and the reaction was started by addition of 0.001 µg/µL PTP1B
stock solution (50 µL) in phosphate buffer (to give a final concentration of 0.05 µg PTP1B per well).
The reaction was monitored at 405 nm every 30 s for 10 min to yield the enzyme activity (expressed
as cleavage rate AU/s) by using a Thermo Scientific Multiskan FC microplate photometer (Thermo
Scientific, Waltham, MA, USA). For each microplate, blank samples (negative controls) containing
buffer, enzyme, EDTA, DTT, and pNPP were measured in triplicate, and for the dilution series, RK682
was included as a reference inhibitory compound (i.e., positive control). The percentage inhibition of
PTP1B was calculated according to the following equation:
% inhibition =
(
1− SLOPEsample
SLOPEblank
)
× 100
The high-resolution PTP1B biochromatograms (high-resolution PTP1B inhibition profiles)
were constructed by plotting the inhibition values against the chromatographic retention time.
Dose-response curves and IC50 values for dilution series of the crude extract and pure compounds
were obtained using GraFit software, version 5.0.11 (Erithacus Software Limited, West Sussex, UK).
For PTP1B IC50 values, the crude extract and isolated compounds were assessed by using the standard
assay conditions described above. Nine dilutions were assessed in triplicates and percentage inhibition
calculated as mean± standard deviation in Microsoft Excel according to the above equation. The results
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were imported and used for assessing dose-response curves and IC50 values in GraFit software, version
5.0.11 (Erithacus Software Limited). Data were fitted to the equation
f(x) = min +
max−min
1 +
(
x
IC50
)slope
where min is the background, max–min is the y-range, x is the concentration, and slope is the Hill
slope. Results are reported as IC50 values ± standard error.
3.4. Microfractionation
Microfractionation of the extract of M. albicans for high-resolution PTP1B inhibition profiling
was conducted using an Agilent 1200 system (Santa Clara, CA, USA—HPLC system 1) comprising
a G1311A quaternary pump, a G1322A degasser, a G1316A thermostatted column compartment,
a G1315C photodiode array detector, a G1367C high-performance autosampler, and a G1364C fraction
collector, controlled by Agilent ChemStation version B.03.02 software. Separations were performed by
using a reversed-phase Phenomenex Luna C18(2) column (150 mm × 4.6 mm i.d., 3 µm particle size,
100 Å pore size) (Phenomenex, Torrance, CA, USA). A binary elution system of water: acetonitrile
(95:5, solvent A) and acetonitrile: water (95:5, solvent B), both acidified with 0.1% formic acid, was
used with a flow rate of 0.8 mL/min. An aliquot (10 µL) of a solution of the crude extract (equivalent
to 200 µg of crude extract) was chromatographically separated using the following stepwise linear
gradient elution profile: 0 min, 0% B; 50 min, 20% B; 60 min, 30% B; 65 min, 50% B; 85 min, 100% B;
105 min, 100% B. The chromatographic eluate was collected into four 96-well microplates (308 wells)
from 20 to 90 min, leading to a biochromatogram with a resolution of 4.4 data points/min. The HPLC
separation of fraction F1 was conducted using a flow rate of 0.8 mL/min, and a binary elution gradient
of water:acetonitrile (95:5, solvent A) and acetonitrile:water (95:5, solvent B), both acidified with 0.1%
formic acid, and the following stepwise linear elution gradient: 0 min, 50% B; 5 min, 55% B; 35 min,
57% B; 36 min, 70% B; 40 min, 90% B; 41 min, 100% B; 51 min, 100% B. For the high-resolution inhibition
profiling of fraction F1, the HPLC eluates in the range 8 min to 36 min were collected into one 96-well
microplate (88 wells used) leading to a resolution of 3.1 data points/min.
3.5. Preparative-Scale HPLC for Fractionation of the Crude Extract of M. albicans
A solution of crude extract of M. albicans was prepared in methanol (100 mg/mL) and fractionated
by 10 consecutive injections of 500 µL using an Agilent 1100 series HPLC system (Santa Clara,
CA, USA—HPLC system 2) comprising a G1361A quaternary pump, a G2260A autosampler, and a
G1365B MWD detector, all controlled by Agilent ChemStation version 3.02 software, equipped with
a Phenomenex (Phenomenex Inc., Torrance, CA, USA) Luna C18(2) column (250 mm × 21.2 mm i.d.,
5 µm particle size, 100 Å pore size). A binary elution system of water: acetonitrile (95:5, solvent A)
and acetonitrile:water (95:5, solvent B), both acidified with 0.1% formic acid was employed under flow
rate of 17 mL/min. The stepwise linear elution gradient was as follows: 0 min, 0% B; 50 min, 20% B;
60 min, 30% B; 65 min, 50% B; 85 min, 100% B; 105 min, 100% B. Fraction F1 was collected from 74 to
90 min (82.0 mg).
3.6. Isolation of PTP1B Inhibitors from the Extract of M. albicans by Analytical-Scale HPLC
The early-eluting PTP1B inhibitors (observed from 32 to 60 min) were isolated directly from the
crude extract using HPLC system 1 operated with the same column, solvent system and flow rate
as described in Section 3.4. Twenty successive injections of 20 µL of a solution of the crude extract
(equivalent to 400 µg of crude extract each) were separated using the stepwise linear elution gradient:
0 min, 0% B; 50 min, 20% B; 60 min, 30% B; 65 min, 50% B; 85 min, 100% B; 105 min, 100% B. The active
compounds observed in the inhibition profile were collected, dried and submitted to analysis by
NMR spectroscopy.
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3.7. HPLC-HRMS-SPE-NMR Analyses of Triterpenoids from F1
HPLC-HRMS-SPE-NMR analyses of fraction F1 were performed on a system comprising an
Agilent 1260 HPLC (Santa Clara, CA, USA), a Bruker micrOTOF-Q II mass spectrometer (Bruker
Daltonik, Bremen, Germany), a Knauer Smartline K120 pump (Knauer, Berlin, Germany), a Spark
Holland Prospekt-2 SPE unit (Spark Holland, Emmen, The Netherlands), a Gilson 215 liquid handler
(Gilson, Middleton, WI, USA), and a Bruker Avance III 600 MHz NMR spectrometer (Bruker Biospin,
Rheinstetten, Germany). The Agilent HPLC system consisted of a G1329B autosampler, a G1311B
quaternary pump with built-in degasser, a G1316A thermostatted column compartment, equipped
with Phenomenex (Phenomenex Inc., Torrance, CA, USA) Luna C18(2) column (150 mm × 4.6 mm
i.d., 3 µm particle size, 100 Å pore size), and a G1315D photodiode array detector, and the column,
elution solvents, temperature, and flow rate were the same as described in Section 3.4. A T-piece after
the HPLC column directed approximately 1% of the eluate to the micrOTOF-Q II mass spectrometer
equipped with an electrospray ionization source. Spectra were acquired in positive ionization mode,
using a drying temperature of 200 ◦C, a capillary voltage of 4100 V, a nebulizer pressure of 2.0 bar, and a
drying gas flow of 7 L/min. To enable internal mass calibration, a solution of sodium formate clusters
was automatically injected at the beginning of each run. The remaining 99% of the eluate was directed
to the photodiode array detector and subsequently diluted with water at a flow rate of 1 mL/min
delivered by the Knauer pump. Hysphere GP-resin SPE cartridges (10 × 2 mm i.d., Spark Holland,
Emmen, The Netherlands) were preconditioned with 500 µL of acetonitrile and equilibrated with
500 µL of water. Selected chromatographic peaks were trapped from 10 consecutive chromatographic
separations using threshold levels from the UV chromatogram (200 nm and 254 nm), the total ion
chromatograms (TIC), or base peak chromatograms (BPC) to trigger trapping. The loaded SPE
cartridges were dried with pressurized N2 gas for 30 min and subsequently eluted with methanol-d4
(30 µL) into 1.7-mm o.d. NMR tubes (Bruker Biospin, Rheinstetten, Germany) using the Gilson liquid
handler equipped with a 1-mm needle. HPLC separations, mass spectrometry and analyte trapping on
SPE cartridges were controlled by Hystar version 3.2 software (Bruker Daltonik, Bremen, Germany),
whereas the elution processes were controlled by Prep Gilson ST version 1.2 software (Bruker Biospin,
Rheinstetten, Germany).
Ten successive injections of 12 µL of methanolic solution of F1 (equivalent to 720 µg) were
separated using a binary elution system consisted of water:acetonitrile (95:5, solvent A) and
acetonitrile:water (95:5, solvent B), both acidified with 0.1% formic acid, under a flow rate of
0.8 mL/min. The separation was performed using the following stepwise linear gradient elution:
0 min, 50% B; 55 min, 80% B; 60 min, 100% B; 62 min, 100% B.
3.8. NMR Experiments
NMR experiments were recorded at 300 K in methanol-d4 and acquired on a Bruker Avance
III 600 MHz NMR spectrometer (1H operating frequency of 600.13 MHz) equipped with a Bruker
SampleJet sample changer and a 1.7-mm cryogenically cooled inverse triple-resonance TCI probe
(Bruker Biospin, Rheinstetten, Germany). The one-dimensional 1H spectra were acquired with 30◦
pulses with a 20 ppm spectral width, 2.72 s acquisition time, and 1.0 s relaxation delay, collecting 256
or 512 FIDS, each consisting of 64 k data points, and Fourier transformed to 256 k data points with a
line broadening of 0.1 Hz. Two-dimensional homonuclear DQF-COSY and NOESY experiments were
recorded using a gradient-based pulse sequence with a 20 ppm spectral width and 2 k × 512 data
points (processed with forward linear prediction to 1 k data points). Multiplicity-edited HSQC spectra
were acquired with 12 ppm spectral width for 1H and 170 ppm for 13C, 2 k × 256 data points, and 1.0 s
relaxation delay. HMBC experiments were recorded with a 12 ppm spectral width for 1H and 210 ppm
for 13C, 2 k × 192 data points and 1.0 s relaxation delay.
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4. Conclusions
In the present study, five flavonoids and eight triterpenoid PTP1B inhibitors were identified by
analysis of the defatted ethyl acetate extract of M. albicans. These included maslinic acid derivatives
with substituents at position C-3, which seem to be potential selective inhibitors. Thus, the combination
of high-resolution inhibition profiling and HPLC-HRMS-SPE-NMR proved to be a powerful tool for
accelerated assessment of plant extracts by providing high-quality analytical data. Further studies to
explore the selectivity of the 3-coumaroylated maslinic acid are needed.
Supplementary Materials: The following material is available online: Figures S1 and S2 with dose-response
curves for crude ethyl acetate extract and compounds 13–20 and Table S1 with HRMS and/or 1H NMR data
acquired in the HPLC-HRMS-SPE-NMR mode of the material eluted with peaks 1–20 of Miconia albicans.
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